Ubs Group Ag I Mab Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.58 - $1.9 $17,669 - $21,247	11,183 Added 840.2%	12,514 $20,000
Q1 2024 May 13, 2024	SELL	$1.54 - $2.37 $21,479 - $33,056	-13,948 Reduced 91.29%	1,331 $2,000
Q4 2023 Feb 09, 2024	SELL	$1.21 - $1.9 $657,361 - $1.03 Million	-543,274 Reduced 97.26%	15,279 $29,000
Q3 2023 Nov 09, 2023	BUY	$1.18 - $3.06 $24,654 - $63,935	20,894 Added 3.89%	558,553 $737,000
Q2 2023 Aug 11, 2023	BUY	$2.95 - $3.85 $19,071 - $24,890	6,465 Added 1.22%	537,659 $1.61 Million
Q1 2023 May 12, 2023	SELL	$3.08 - $7.39 $37,816 - $90,734	-12,278 Reduced 2.26%	531,194 $1.84 Million
Q4 2022 Feb 08, 2023	BUY	$3.22 - $4.86 $1.39 Million - $2.1 Million	432,657 Added 390.43%	543,472 $2.27 Million
Q3 2022 Nov 10, 2022	SELL	$4.01 - $12.34 $434,459 - $1.34 Million	-108,344 Reduced 49.44%	110,815 $444,000
Q2 2022 Aug 10, 2022	BUY	$8.27 - $18.43 $966,911 - $2.15 Million	116,918 Added 114.36%	219,159 $2.48 Million
Q1 2022 May 16, 2022	BUY	$12.54 - $46.93 $395,975 - $1.48 Million	31,577 Added 44.69%	102,241 $1.66 Million
Q4 2021 Feb 14, 2022	SELL	$45.28 - $74.5 $1.07 Million - $1.76 Million	-23,638 Reduced 25.07%	70,664 $3.35 Million
Q3 2021 Nov 15, 2021	SELL	$57.18 - $84.43 $4.33 Million - $6.39 Million	-75,692 Reduced 44.53%	94,302 $6.84 Million
Q2 2021 Aug 13, 2021	BUY	$47.86 - $83.95 $8.1 Million - $14.2 Million	169,334 Added 25656.67%	169,994 $14.3 Million
Q1 2021 May 12, 2021	BUY	$44.38 - $63.97 $2,840 - $4,094	64 Added 10.74%	660 $32,000
Q4 2020 Feb 11, 2021	SELL	$32.94 - $47.15 $580,666 - $831,160	-17,628 Reduced 96.73%	596 $28,000
Q3 2020 Nov 12, 2020	BUY	$27.46 - $47.03 $500,431 - $857,074	18,224 New	18,224 $857,000
Q2 2020 Jul 31, 2020	SELL	$13.0 - $31.0 $25,805 - $61,535	-1,985 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$10.63 - $15.37 $21,100 - $30,509	1,985 New	1,985 $26,000

Others Institutions Holding IMAB

# of Institutions

Shares Held

15.5M

Call Options Held

56.4K

Put Options Held

5.8K

Hhlr Advisors, Ltd. Grand Cayman, E9

6.91M
Shares

$6.22 Million
0.2% of portfolio
Decheng Capital Management Iii (Cayman), LLC

4.17M
Shares

$3.75 Million
3.04% of portfolio
Boothbay Fund Management, LLC New York, NY

1.42M
Shares

$1.28 Million
0.05% of portfolio
Temasek Holdings (Private) LTD Singapore, U0

567K
Shares

$509,985
0.0% of portfolio
David A. Siegel Two Sigma Advisers, LP | New York, Ny

499K
Shares

$449,370
0.0% of portfolio

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $74.8M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account